Phosphodiesterase 10A (PDE10A) is a key enzyme of intracellular signal transduction which is involved in the regulation of neurotransmission. The molecular imaging of PDE10A by PET is expected to allow a better understanding of physiological and pathological processes related to PDE10A expression and function in the brain. The aim of this study was to develop a new 18F-labeled PDE10A ligand based on a 6,7-dimethoxy-4-pyrrolidinylquinazoline and to evaluate its properties in biodistribution studies. Nucleophilic substitution of the 7-tosyloxy-analogue led to the 7-[18F]fluoroethoxy-derivative [18F]IV with radiochemical yields of 25% ± 9% (n = 9), high radiochemical purity of ≥99% and specific activities of 110-1,100 GBq/μmol. [18F]IV showed moderate PDE10A affinity (KD,PDE10A = 14 nM) and high metabolic stability in the brain of female CD-1 mice, wherein the radioligand entered rapidly with a peak uptake of 2.3% ID/g in striatum at 5 min p.i. However, ex vivo autoradiographic and in vivo blocking studies revealed no target specific accumulation and demonstrated [18F]IV to be inapplicable for imaging PDE10A with PET. © 2012 by the authors; licensee MDPI, Basel, Switzerland.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Funke, U., Deuther-Conrad, W., Schwan, G., Maisonial, A., Scheunemann, M., Fischer, S., … Brust, P. (2012). Radiosynthesis and radiotracer properties of a 7-(2-[18f]fluoroethoxy)-6-methoxypyrrolidinylquinazoline for imaging of phosphodiesterase 10a with PET. Pharmaceuticals, 5(2), 169–188. https://doi.org/10.3390/ph5020169